Cytomegalovirus Infection in Pregnancy - Counselling Challenges in the Setting of Generalised Testing

Overview

Journal Maedica (Bucur)

Specialty General Medicine

Date 2020 Sep 21

PMID 32952692

Citations 3

Authors

Anca Maria Ciobanu

Nicolae Gica

Corina Gica

Radu Botezatu

Mirona Furtuna

Gheorghe Peltecu

Anca Maria Panaitescu

Affiliations

Soon will be listed here.

Abstract

Cytomegalovirus (CMV) is the most common cause of perinatal viral infection, affecting 0.2-2.2% of all neonates, with variation among different study populations. It can cause serious long-term neurological sequelae, being the leading cause of non-genetic congenital hearing loss. The risk of congenital infection is highest after primary maternal infection, varying between 30-70% and depending on the gestational age at the time of infection. Although CMV can have serious neurodevelopmental consequences, in most developed countries current guidelines do not recommend routine screening for CMV in pregnancy, since current tests have a low predictive value for cases with serious adverse outcome and efficient therapeutic options are not standardized yet. In Romania there is a routine clinical practice to offer screening for most common causes of infections, including CMV, in the first trimester of pregnancy In these settings, this review summarizes the current methods of diagnosis and management of CMV infection in pregnancy.

Citing Articles

Seroprevalence of cytomegalovirus among pregnant women in Singapore.

Partana P, Wan W, Chow X, Yen Chan J, Tan L, Tan W Trop Med Health. 2024; 52(1):67.

PMID: 39363362 PMC: 11451239. DOI: 10.1186/s41182-024-00634-z.

Screening for TORCH Antibodies in Croatian Childbearing-Aged Women, 2014-2023.

Vilibic-cavlek T, Kolaric B, Belamaric M, Sviben M, Ferenc T, Navolan D Antibodies (Basel). 2024; 13(2).

PMID: 38920973 PMC: 11200394. DOI: 10.3390/antib13020049.

Pathogenesis of viral infections during pregnancy.

Creisher P, Klein S Clin Microbiol Rev. 2024; 37(2):e0007323.

PMID: 38421182 PMC: 11237665. DOI: 10.1128/cmr.00073-23.

References

Yamamoto A, Mussi-Pinhata M, Isaac M, Amaral F, Carvalheiro C, Aragon D . Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011; 30(12):1043-6. PMC: 3222783. DOI: 10.1097/INF.0b013e31822d9640. View

Boppana S, Rivera L, Fowler K, Mach M, Britt W . Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001; 344(18):1366-71. DOI: 10.1056/NEJM200105033441804. View

Grangeot-Keros L, Mayaux M, Lebon P, Freymuth F, Eugene G, Stricker R . Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 1997; 175(4):944-6. DOI: 10.1086/513996. View

Visentin S, Manara R, Milanese L, Da Roit A, Forner G, Salviato E . Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis. 2012; 55(4):497-503. DOI: 10.1093/cid/cis423. View

Kimberlin D, Lin C, Sanchez P, Demmler G, Dankner W, Shelton M . Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003; 143(1):16-25. DOI: 10.1016/s0022-3476(03)00192-6. View

Leruez-Ville M, Ghout I, Bussieres L, Stirnemann J, Magny J, Couderc S . In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016; 215(4):462.e1-462.e10. DOI: 10.1016/j.ajog.2016.04.003. View

Oliver S, Cloud G, Sanchez P, Demmler G, Dankner W, Shelton M . Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009; 46 Suppl 4:S22-6. PMC: 2805252. DOI: 10.1016/j.jcv.2009.08.012. View

Fowler K, Stagno S, Pass R, Britt W, Boll T, Alford C . The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992; 326(10):663-7. DOI: 10.1056/NEJM199203053261003. View

Gaytant M, Rours G, Steegers E, Galama J, Semmekrot B . Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr. 2003; 162(4):248-53. DOI: 10.1007/s00431-002-1115-5. View

10.

Fowler K, Boppana S . Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006; 35(2):226-31. DOI: 10.1016/j.jcv.2005.09.016. View

11.

Britt W . Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol. 2015; 204(3):263-71. DOI: 10.1007/s00430-015-0399-9. View

12.

Donner C, Liesnard C, Brancart F, RODESCH F . Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn. 1994; 14(11):1055-9. DOI: 10.1002/pd.1970141108. View

13.

Pass R, Fowler K, Boppana S, Britt W, Stagno S . Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2005; 35(2):216-20. DOI: 10.1016/j.jcv.2005.09.015. View

14.

Farkas N, Hoffmann C, Ben-Sira L, Lev D, Schweiger A, Kidron D . Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection?. Prenat Diagn. 2011; 31(4):360-6. DOI: 10.1002/pd.2694. View

15.

Picone O, Vauloup-Fellous C, Cordier A, Guitton S, Senat M, Fuchs F . A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn. 2013; 33(8):751-8. DOI: 10.1002/pd.4118. View

16.

Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A . Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn. 2001; 21(5):362-77. DOI: 10.1002/pd.59. View

17.

Kenneson A, Cannon M . Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007; 17(4):253-76. DOI: 10.1002/rmv.535. View

18.

Alford C, Stagno S, Pass R, Britt W . Congenital and perinatal cytomegalovirus infections. Rev Infect Dis. 1990; 12 Suppl 7:S745-53. DOI: 10.1093/clinids/12.supplement_7.s745. View

19.

Kagan K, Enders M, Schampera M, Baeumel E, Hoopmann M, Geipel A . Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration. Ultrasound Obstet Gynecol. 2018; 53(3):383-389. DOI: 10.1002/uog.19164. View

20.

Enders G, Daiminger A, Bader U, Exler S, Enders M . Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011; 52(3):244-6. DOI: 10.1016/j.jcv.2011.07.005. View